Stefan Heytens
Overview
Explore the profile of Stefan Heytens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyers E, De Rop L, Deschepper E, Duysburgh E, De Burghgraeve T, Van Ngoc P, et al.
Vaccine
. 2025 Feb;
51:126865.
PMID: 39983537
Background: During COVID-19 vaccine implementation, information on the persistence of antibody response and impact on mortality in nursing home residents was limited, as they were underrepresented in vaccine clinical trials...
2.
Piessens V, Van den Bruel A, Piessens A, Van Hecke A, Brandt Brodersen J, Lauwerier E, et al.
PLoS One
. 2025 Feb;
20(2):e0315247.
PMID: 39899650
Introduction: Medical screening is a major driver of overdiagnosis, which should be considered when making an informed screening decision. Health professionals (HPs) often initiate screening and are therefore responsible for...
3.
Anh Hien H, Tam N, Van Minh H, Binh Thang T, Phuoc Hoang L, Heytens S, et al.
PLoS One
. 2025 Jan;
20(1):e0307588.
PMID: 39874240
Background: Medication adherence plays a crucial role in effectively managing hypertension, a significant public health concern, especially in regions like Central Vietnam. This study aimed to assess medication adherence levels...
4.
De Rop L, Vercruysse H, Alenus U, Brusselmans J, Callens S, Claeys M, et al.
Viruses
. 2024 Sep;
16(9).
PMID: 39339937
(1) Background: early in the COVID-19 pandemic, reverse transcription polymerase chain reaction (RT-PCR) testing was limited. Assessing seroprevalence helps understand prevalence and reinfection risk. However, such data are lacking for...
5.
Meyers E, De Rop L, Engels F, Gioveni C, Coen A, De Burghgraeve T, et al.
Vaccines (Basel)
. 2024 Aug;
12(8).
PMID: 39204074
When COVID-19 vaccines were implemented, nursing home residents (NHRs) and staff (NHS) in Belgium were prioritized for vaccination. To characterize the vaccine response over time in this population and to...
6.
Stul F, Heytens S, Ebo D, Sabato V, Piessens V
J Allergy Clin Immunol Pract
. 2024 Jun;
12(9):2415-2426.e1.
PMID: 38901618
Background: Ten percent of the population is labeled as allergic to penicillin(s), when in fact 90% of these labels are inappropriate. Recent studies have shown that inpatient delabeling by a...
7.
Rabaey P, Decat P, Heytens S, Vogelaers D, Mariman A, Demeester T
Biopsychosoc Med
. 2024 Apr;
18(1):10.
PMID: 38566157
Background: Chronic Fatigue Syndrome patients suffer from symptoms that cannot be explained by a single underlying biological cause. It is sometimes claimed that these symptoms are a manifestation of a...
8.
Digregorio M, Van Ngoc P, Delogne S, Meyers E, Deschepper E, Dardenne N, et al.
Vaccine X
. 2024 Feb;
16:100453.
PMID: 38361529
In Belgium, nursing home (NH) staff (NHS) and residents were prioritised for the initial COVID-19 vaccination and successive booster doses. The vaccination campaign for the first booster started in September...
9.
Burvenich R, Heytens S, De Sutter A, Struyf T, Toelen J, Verbakel J
Arch Dis Child
. 2023 Dec;
109(2):93-99.
PMID: 38123917
Objective: Develop a consensus on the content and form of safety netting advice (SNA) for parents of acutely ill children. Design: Four-round modified e-Delphi using online questionnaires and feedback among...
10.
Tare D, Coenen S, De Sutter A, Heytens S, Devroey D, Buret L, et al.
BJGP Open
. 2023 Nov;
8(2).
PMID: 37984980
Background: The DAWN antivirals trial was a multicentric, randomised placebo-controlled trial evaluating antiviral medication for COVID-19 in general practice. The trial was prematurely terminated because of insufficient recruitment. Aim: To...